sorafenib
bayer
[]
an emerging theme in the hepatobiliary section of #gi23 - combining local therapies (tace, sbrt) with sorafenib. appealing ways to get more mileage from otherwise cytostatic treatment.
MD/PhD Heme/Onc fellow @WUSTL
GI cancers || single-cell genomics
Proud dad, fish keeper, language learner
https://t.co/m7AbNIgWB4 || https://t.co/4Nu6wdD8o7